These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Challenges of randomized controlled surgical trials. Campbell AJ; Bagley A; Van Heest A; James MA Orthop Clin North Am; 2010 Apr; 41(2):145-55. PubMed ID: 20399354 [TBL] [Abstract][Full Text] [Related]
24. Quality assurance and technology assessment: pieces of a larger puzzle. McDonald IG J Qual Clin Pract; 2000; 20(2-3):87-94. PubMed ID: 11057990 [TBL] [Abstract][Full Text] [Related]
25. Using evidence to inform coverage decisions: the Washington State experience. Blackmore CC Acad Radiol; 2012 Sep; 19(9):1055-9. PubMed ID: 22877985 [TBL] [Abstract][Full Text] [Related]
26. Healthcare technology assessment: methods, framework, and role in policy making. Goodman CS Am J Manag Care; 1998 Sep; 4 Spec No():SP200-14; quiz SP215-6. PubMed ID: 10185995 [TBL] [Abstract][Full Text] [Related]
27. Clinical trials of cost effectiveness in technology evaluation. Valk PE Q J Nucl Med; 2000 Jun; 44(2):197-203. PubMed ID: 10967629 [TBL] [Abstract][Full Text] [Related]
28. A primer on the assessment of medical technologies. Matuszewski KA Pharm Pract Manag Q; 1997 Jan; 16(4):53-65. PubMed ID: 10164160 [TBL] [Abstract][Full Text] [Related]
29. Historical development of health technology assessment in Thailand. Teerawattananon Y; Tantivess S; Yothasamut J; Kingkaew P; Chaisiri K Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():241-52. PubMed ID: 19527543 [TBL] [Abstract][Full Text] [Related]
30. [Opportunities of conventional evaluation in complementary and alternative medicine]. Willich SN Z Arztl Fortbild Qualitatssich; 2005; 99(4-5):307-11. PubMed ID: 16044790 [TBL] [Abstract][Full Text] [Related]
31. Role of health technology assessment in shaping the benefits package in The Netherlands. Stolk EA; de Bont A; van Halteren AR; Bijlmer RJ; Poley MJ Expert Rev Pharmacoecon Outcomes Res; 2009 Feb; 9(1):85-94. PubMed ID: 19371181 [TBL] [Abstract][Full Text] [Related]
32. Technology assessment in medicine: methods, status and trends. Hendee WR Med Prog Technol; 1991; 17(2):69-75. PubMed ID: 1835752 [TBL] [Abstract][Full Text] [Related]
33. Do randomized controlled nursing trials have a pragmatic or explanatory attitude? Findings from the Pragmatic-Explanatory Continuum Indicator Summary (PRECIS) tool exercise. Palese A; Bevilacqua MG; Dante A; J Nurs Res; 2014 Sep; 22(3):216-20. PubMed ID: 25111115 [TBL] [Abstract][Full Text] [Related]
35. Conditionally funded field evaluations: PATHs coverage with evidence development program for Ontario. Goeree R; Chandra K; Tarride JE; O'Reilly D; Xie F; Bowen J; Blackhouse G; Hopkins R Value Health; 2010 Jun; 13 Suppl 1():S8-11. PubMed ID: 20618796 [No Abstract] [Full Text] [Related]
36. A comparison of national guidelines for network meta-analysis. Laws A; Kendall R; Hawkins N Value Health; 2014 Jul; 17(5):642-54. PubMed ID: 25128059 [TBL] [Abstract][Full Text] [Related]
37. Closing the cycle of innovation in healthcare in Europe. Hulstaert F; Ruether A; Demotes J; Melien Ø Int J Technol Assess Health Care; 2020 Apr; 36(2):75-79. PubMed ID: 31948497 [TBL] [Abstract][Full Text] [Related]
38. [Improving health care practices and organization: methodology for intervention studies]. Zaugg V; Savoldelli V; Sabatier B; Durieux P Sante Publique; 2014; 26(4):519-29. PubMed ID: 25380267 [TBL] [Abstract][Full Text] [Related]
39. [The role of randomised controlled trials in the medical evaluation of routine procedures]. Lange S Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Mar; 49(3):272-7. PubMed ID: 16465518 [TBL] [Abstract][Full Text] [Related]
40. Scientific Evidence in Health Technology Assessment Reports: An In-Depth Analysis of European Assessments on High-Risk Medical Devices. Olberg B; Fuchs S; Panteli D; Perleth M; Busse R Value Health; 2017 Dec; 20(10):1420-1426. PubMed ID: 29241902 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]